A Multicenter, Randomized, Evaluator Blinded, Active-Controlled Study to Evaluate the Safety and Efficacy of Oral SCY-078 vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis

Trial Profile

A Multicenter, Randomized, Evaluator Blinded, Active-Controlled Study to Evaluate the Safety and Efficacy of Oral SCY-078 vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Aug 2017

At a glance

  • Drugs SCY 078 (Primary) ; Fluconazole
  • Indications Vulvovaginal candidiasis
  • Focus Proof of concept; Therapeutic Use
  • Sponsors SCYNEXIS
  • Most Recent Events

    • 14 Aug 2017 According to a Scynexis media release, results from this trial were presented at the 2017 Infectious Diseases Society for Obstetrics and Gynecology (IDSOG) Annual Meeting.
    • 08 Aug 2017 According to a Scynexis media release, results from this trial will be presented at the 2017 Infectious Diseases Society for Obstetrics and Gynecology (IDSOG) Annual Meeting.
    • 24 May 2017 Data from this trial will be presented at the ASM Microbe 2017, according to a SCYNEXIS media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top